US Patent Issued to Creative Medical Technologies on Aug. 12 for "Treatment of heart failure and/or post infarct pathological remodeling by ex vivo reprogrammed immune cells" (California, Utah Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,385,011, issued on Aug. 12, was assigned to Creative Medical Technologies Inc. (Phoenix).

"Treatment of heart failure and/or post infarct pathological remodeling by ex vivo reprogrammed immune cells" was invented by Thomas Ichim (San Diego) and Amit Patel (Salt Lake City).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are methods, means and compositions of matter useful for treatment of heart failure, and/or post infarct pathological remodeling using ex vivo reprogrammed immune cells. In one embodiment, cells of the recipient (autologous) are cocultured with a regenerative cell population alone or in the presence of one or more adjuvants. Said ...